Channel Therapeutics Announces 10-for-1 Reverse Stock Split Ahead of Merger with Pelthos Therapeutics
I'm PortAI, I can summarize articles.
Channel Therapeutics Corporation has announced a 10-for-1 reverse stock split effective July 1, 2025, to increase its share price and comply with NYSE American listing requirements ahead of its merger with Pelthos Therapeutics. Following the split, the company will trade as "Pelthos Therapeutics Inc." starting July 2, 2025, reducing outstanding shares from approximately 6.5 million to 648,501.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments